Cargando…
First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic
BACKGROUND: Long-acting injectable antiretroviral therapy (LAI-ART) is approved for treatment-naive or experienced people with human immunodeficiency virus (HIV; PWH) based on trials that only included participants with viral suppression. We performed the first LAI-ART demonstration project to inclu...
Autores principales: | Christopoulos, Katerina A, Grochowski, Janet, Mayorga-Munoz, Francis, Hickey, Matthew D, Imbert, Elizabeth, Szumowski, John D, Dilworth, Samantha, Oskarsson, Jon, Shiels, Mary, Havlir, Diane, Gandhi, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907477/ https://www.ncbi.nlm.nih.gov/pubmed/35913500 http://dx.doi.org/10.1093/cid/ciac631 |
Ejemplares similares
-
1585. The Annual Cost per Newly Virally-Suppressed Person with HIV in Those Starting Long-Acting Injectable Antiretroviral Therapy with Detectable Viremia in a Safety-Net Clinic in San Francisco
por: Marseille, Elliot, et al.
Publicado: (2023) -
Impact of Multicomponent Support Strategies on Human Immunodeficiency Virus Virologic Suppression Rates During Coronavirus Disease 2019: An Interrupted Time Series Analysis
por: Spinelli, Matthew A, et al.
Publicado: (2022) -
Housing Instability Results in Increased Acute Care Utilization in an Urban HIV Clinic Cohort
por: Clemenzi-Allen, Angelo, et al.
Publicado: (2019) -
Antiretroviral Refill Histories as a Predictor of Future Human Immunodeficiency Virus Viremia
por: Sokpa, Darryl, et al.
Publicado: (2022) -
Cumulative Human Immunodeficiency Virus (HIV)-1 Viremia Is Associated With Increased Risk of Multimorbidity Among US Women With HIV, 1997–2019
por: Morton, Zoey P, et al.
Publicado: (2022)